10x Genomics Inc Ordinary Shares - Class A (TXG)
Industry Health Information Services
This stock can be held in an Investment ISA and an Investment Account
Sell
$15.46
Buy
$15.75
$-1.08 (-6.53%)
Prices updated at 13 Dec 2025, 00:27 EST
| Prices minimum 15 mins delay
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 67.86 |
| 2023 | 66.15 |
| 2022 | 76.69 |
| 2021 | 84.89 |
| 2020 | 80.44 |
| 2019 | 75.18 |
| 2018 | 80.41 |
| 2017 | 85.14 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 2.97 |
| 2024 | 2.73 |
| 2023 | 11.00 |
| 2022 | 8.19 |
| 2021 | 35.43 |
| 2020 | 53.23 |
| 2019 | 33.14 |
Price/Forward earnings (YTD)
-23.47
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -19.39 |
| 2023 | -25.59 |
| 2022 | -16.21 |
| 2021 | -5.98 |
| 2020 | -70.70 |
| 2019 | -8.56 |
| 2018 | -112.53 |
| 2017 | -24.81 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.29 |
| 2023 | 1.30 |
| 2022 | 1.28 |
| 2021 | 1.25 |
| 2020 | 1.26 |
| 2019 | 1.44 |
| 2018 | - |
| 2017 | - |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.